Wednesday, May 27, 2015 3:47:18 PM
the opposite of yesterday....this stock seems to be putting in a bottom. We almost had an "inflection point" over a week ago with all the demand volume. Now we are bouncing around again on much smaller volume of sales.
Wonder when our friends in Xinyang will finally let us in on their plans for AIVtech?
It has been over 5 months since there has been an AIV news release, even in China. I speculate that something significant is going on this year. BUT WHAT THE HELL IS IT? GOOD OR BAD STOCKHOLDERS??
The last public post from coolbluewater was something to the effect that management was waiting for new product development or market demand on recent product lines.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113324491
As to the former, OLED is the only known and promised new product development. The OLED factory must have been completed well over 6 months ago! See the late 2013 construction progress photos in the yellow sticky posts from gje2. Could they have scraped their AMOLED plans and decided to manufacture some new product in the new factory?
As to the latter, the only newish product line that we know about are the Otter computer chairs and the 4 smart phones on the AIV website. Have they not been selling to meet expectations? We stockholders need to know!!!
Coolbluewater water implied these issues need to be cleared up before the company decides what to do. Well it has taken 6 months already with no significant reports from AIV even to the Chinese press. I suppose there are no Chinese investors to keep informed other than the 2 or 3 Chinese nationals/insiders who own approximately 50% of AIV common stock. If it were not for their holdings and human nature to want to exploit an owned asset, I would be out of this stock. Human greed being what it is, I am still counting on the insiders to promote this stock later this year. Be it for company equity financing or for personal gains, I still think they will promote the hell out of AIVI sooner or later. THAT IS OUT RISK AND THAT IS OUR PROFIT POTENTIAL IF WE GET THE TIME AND HAVE A REASONABLE EXIT STRATEGY!
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM